Arvinas Estrogen Receptor, Inc.
Overview
Arvinas Estrogen Receptor, Inc. is a biotechnology company focused on the development of therapies targeting the estrogen receptor with the aim of treating hormone-driven cancers. It specializes in novel PROTAC® (PROteolysis TArgeting Chimera) protein degraders for innovative treatments.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Arvinas Estrogen Receptor, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.